Probiotic versus antibiotic for small intestinal bacterial overgrowth
Treatments studied
Part of Digestive system clinical trials.
This trial compares two treatments for SIBO, a condition that causes bloating and diarrhea due to too much bacteria in the small intestine. One treatment is a probiotic (a beneficial yeast) and the other is an antibiotic. The goal is to see which one works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You need to have bloating (abdominal distension) or frequent diarrhea.
- You must have a positive breath test for SIBO (a certain type of bacteria in your small intestine).
- You cannot be pregnant or breastfeeding, and you must not have had stomach surgery or stomach cancer.
- You cannot have diabetes, kidney disease, immune system problems, Parkinson's disease, or a psychiatric condition like severe depression or anxiety.
- You must stop certain medications (like antibiotics, probiotics, or some stomach medicines) for at least 2 weeks before the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a probiotic supplement to the antibiotic rifaximin improves treatment for people with irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO), a condition where too many bacteria grow in the small intestine. If you have IBS and SIBO, this combination might help reduce your symptoms.
This trial tests whether a herbal supplement called Biocidin REMOVE can help people with irritable bowel syndrome (IBS) who also have a condition called small intestinal bacterial overgrowth (SIBO), where too many bacteria grow in the small intestine. The study aims to see if the supplement can reduce symptoms and improve quality of life.
This trial tests whether a supplement made from Artemisia annua (sweet wormwood) can help people with SIBO, a gut condition. You will take the supplement or a placebo for 5 weeks and have breath tests and blood draws to see how it affects your symptoms.
This study tests whether the antibiotic rifaximin can relieve bloating in people with small intestinal bacterial overgrowth (SIBO). If you have chronic bloating and a positive SIBO breath test, this trial may be a good fit.
This study tests how Rifaximin (a medicine for SIBO) affects the bacteria and other substances in your gut. You'll swallow a small capsule that collects samples as it travels through your digestive system, so researchers can see how your gut changes during treatment.
This early study tests whether fecal microbiota transplant (a stool donation placed into the gut) is safe and practical for children with small intestinal bacterial overgrowth (SIBO). It may help reduce SIBO symptoms, but the main goal is to see if the treatment and study steps work well.
Hear when a new Small Intestinal Bacterial Overgrowth Syndrome (SIBO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.